Pharmaceutical
Ananda Pharma Confirms Safety of MRX1 CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
endometriosis
5stories
17 Junlast updated
More in endometriosis
- Your #1 Podcast on Cannabis News
Quick Hits with Michelle Arbus, Strainprint & Dr. Prutchi Sagiv, Gynica
Last week, Strainprint, a leader in cannabis data and analytics, announced a partnership with Israeli research leaders, Lumir Lab and Gynica to conduct the world’s first international clinical study on the use of cannabis to treat endometriosis.
